Dark Forest Capital Management LP Buys Shares of 6,167 Halozyme Therapeutics, Inc. (NASDAQ:HALO)

Dark Forest Capital Management LP is a private equity firm that specializes in investing in healthcare and biotechnology companies. The company was founded in 2014 by Dr. Eric Lefkofsky, who is also the founder of Groupon and Elevance Health.

Halozyme Therapeutics, Inc. is a biopharmaceutical company that develops and commercializes enzyme-based medicines for cancer treatment. The company's flagship product, Cerezyme, is used to treat pancreatic cancer by breaking down the tumor's proteins and making them more vulnerable to attack by the immune system.

In its most recent filing with the Securities & Exchange Commission, Dark Forest Capital Management LP disclosed that it bought 6,167 shares of Halozyme Therapeutics, Inc.'s stock during the third quarter. The value of this investment was approximately $236,000.

It is worth noting that Dark Forest Capital Management LP is not the only hedge fund to have recently invested in Halozyme Therapeutics, Inc. Other hedge funds, including Renaissance Technologies and Citadel Securities, have also recently purchased shares of the company's stock.

Overall, this investment by Dark Forest Capital Management LP suggests that the firm believes that Halozyme Therapeutics, Inc.'s enzyme-based medicines have significant potential for success in the treatment of cancer.